Anti-angiotensin Therapy: New Perspectives

Kumudha Ramasubbu; Douglas L. Mann; Anita Deswal

doi:10.1016/j.ccl.2007.09.003

Anti-angiotensin Therapy: New Perspectives

Kumudha Ramasubbu, Douglas L. Mann, Anita Deswal

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Activation of the renin-angiotensin system (RAS) plays an important role in the pathogenesis of heart failure. Thus, strategies for the treatment of heart failure have focused on agents that block the RAS. More recently, the role of angiotensin receptor blockers (ARBs) in heart failure therapy has been better defined. This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials.

Original language	English
Pages (from-to)	573-580
Number of pages	8
Journal	Cardiology clinics
Volume	25
Issue number	4
DOIs	https://doi.org/10.1016/j.ccl.2007.09.003
State	Published - Nov 2007

Access to Document

10.1016/j.ccl.2007.09.003

Cite this

@article{ef70870b0bbc4a2894a765ef9ea3cddb,

title = "Anti-angiotensin Therapy: New Perspectives",

abstract = "Activation of the renin-angiotensin system (RAS) plays an important role in the pathogenesis of heart failure. Thus, strategies for the treatment of heart failure have focused on agents that block the RAS. More recently, the role of angiotensin receptor blockers (ARBs) in heart failure therapy has been better defined. This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials.",

author = "Kumudha Ramasubbu and Mann, {Douglas L.} and Anita Deswal",

year = "2007",

month = nov,

doi = "10.1016/j.ccl.2007.09.003",

language = "English",

volume = "25",

pages = "573--580",

journal = "Cardiology clinics",

issn = "0733-8651",

number = "4",

}

TY - JOUR

T1 - Anti-angiotensin Therapy

T2 - New Perspectives

AU - Ramasubbu, Kumudha

AU - Mann, Douglas L.

AU - Deswal, Anita

PY - 2007/11

Y1 - 2007/11

N2 - Activation of the renin-angiotensin system (RAS) plays an important role in the pathogenesis of heart failure. Thus, strategies for the treatment of heart failure have focused on agents that block the RAS. More recently, the role of angiotensin receptor blockers (ARBs) in heart failure therapy has been better defined. This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials.

AB - Activation of the renin-angiotensin system (RAS) plays an important role in the pathogenesis of heart failure. Thus, strategies for the treatment of heart failure have focused on agents that block the RAS. More recently, the role of angiotensin receptor blockers (ARBs) in heart failure therapy has been better defined. This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=36549019487&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2007.09.003

DO - 10.1016/j.ccl.2007.09.003

M3 - Review article

C2 - 18063161

AN - SCOPUS:36549019487

SN - 0733-8651

VL - 25

SP - 573

EP - 580

JO - Cardiology clinics

JF - Cardiology clinics

IS - 4

ER -

Anti-angiotensin Therapy: New Perspectives

Abstract

Access to Document

Other files and links

Fingerprint

Cite this